Supplemental material
Open access
0
Views
0
CrossRef citations to date
0
Altmetric
Novel Vaccines
Immunogenicity and safety of an Entamoeba histolytica adjuvanted protein vaccine candidate (LecA+GLA-3M-052 liposomes) in rhesus macaques
Mayuresh M. Abhyankara Division of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USAView further author information
, Feifan Xua Division of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USAView further author information
, Deborah Chavezb Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USAView further author information
, Anna Goodroeb Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USAView further author information
, Elda Mendozab Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USAView further author information
, Christopher Chenb Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USAView further author information
, Dhiraj K. Singhb Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USAView further author information
, Fernando Varnador Jr.b Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USAView further author information
, Sandra J. Sivananthanc Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USAhttps://orcid.org/0009-0008-1707-7326View further author information
, Robert Kinseyc Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USAView further author information
, William R. Lykinsc Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USAhttps://orcid.org/0000-0001-5677-8733View further author information
, Brynn M. Murphyd Department of Mechanical Engineering, University of Alberta, Edmonton, AB, CanadaView further author information
, Andrew R. Martind Department of Mechanical Engineering, University of Alberta, Edmonton, AB, CanadaView further author information
, Mark A. Tomaie Contract Employee for 3M Healthcare, Saint Paul, MN, USAView further author information
, Soutik Ghosalf Division of Biostatistics, Department of Public Health Sciences, School of Medicine, University of Virginia, Charlottesville, VA, USAView further author information
, Corey Casperc Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA;g Department of Medicine, University of Washington, Seattle, WA, USA;h Department of Global Health, University of Washington, Seattle, WA, USA;i Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, USAhttps://orcid.org/0000-0002-3609-661XView further author information
, Karl Pedersenj Process Development, TechLab Inc, Blacksburg, VA, USAView further author information
, William A. Petri Jr.a Division of Infectious Diseases and International Health, School of Medicine, University of Virginia Health System, Charlottesville, VA, USAView further author information
& Christopher B. Foxc Formulations, Access to Advanced Health Institute (AAHI), Seattle, WA, USA;h Department of Global Health, University of Washington, Seattle, WA, USACorrespondence[email protected]
https://orcid.org/0000-0002-4644-2619View further author information
show allhttps://orcid.org/0000-0002-4644-2619View further author information
Article: 2374147
|
Received 23 Apr 2024, Accepted 26 Jun 2024, Published online: 01 Aug 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.